We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
AUM
$760M
AUM Growth
Cap. Flow
+$748M
Cap. Flow %
98.49%
Top 10 Hldgs %
68.93%
Holding
31
New
31
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 59.03%
2 Technology 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
26
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$6.56M 0.86%
+100,000
New +$6.18M
XENT
27
DELISTED
Intersect ENT, Inc
XENT
$5.61M 0.74%
+249,296
New +$4.93M
SRGA
28
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4.96M 0.65%
+41,667
New +$5.38M
VAR
29
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
$2.83M 0.37%
+39,913
New +$2.76M
GKOS icon
30
Glaukos
GKOS
$9.83B
$1.89M 0.25%
+76,502
New +$1.76M
STRM
31
DELISTED
Streamline Health Solutions
STRM
$1.6M 0.21%
+75,867
New +$2.06M

Similar funds

Tamarack Advisers's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for Tamarack Advisers, which disclosed 31 positions worth $760M. Its ten largest holdings account for 69% of the portfolio.

Its largest position is Patterson Companies, Inc.: 1,050,000 shares worth $47.5M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, followed by Technology.

  • Tamarack Advisers's largest Q4 2015 buy was Patterson Companies, Inc.: 1,050,000 shares worth $47.5M.
  • Tamarack Advisers's ten largest holdings make up 69% of its $760M portfolio in Q4 2015.
  • Tamarack Advisers disclosed 31 positions in Q4 2015, its first 13F filing on record.

Based on Tamarack Advisers's 13F filing for Q4 2015, filed 8 Feb 2016.